Epidemiology of polypharmacy and potential drug-drug interactions among pediatric patients in ICUs of U.S. children's hospitals

Pediatric Critical Care Medicine

Volumn 17, Issue 5, 2016, Pages e218-e228

  Dai, Dingwei ^a   Feinstein, James A ^b,c   Morrison, Wynne ^a,d   Zuppa, Athena F ^a   Feudtner, Chris ^a,d  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

^c University of Colorado Denver and Children s Hospital Colorado   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

drug utilization; drug drug interaction; intensive care; pediatrics; pharmacoepidemiology; polypharmacy

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALTEPLASE; ATROPINE; BUPIVACAINE; DOPAMINE; FENTANYL; FLUCONAZOLE; FUROSEMIDE; GLYCOPYRRONIUM BROMIDE; HEPARIN; HYDROMORPHONE; IBUPROFEN; KETOROLAC; LIDOCAINE; LINEZOLID; LORAZEPAM; METOCLOPRAMIDE; MIDAZOLAM; MORPHINE; NITROPRUSSIDE SODIUM; NORADRENALIN; ONDANSETRON; POTASSIUM CHLORIDE; PROMETHAZINE; PROPOFOL; RANITIDINE; SILDENAFIL; UNINDEXED DRUG; VECURONIUM;

ARTICLE; CAUCASIAN; CHILD; COHORT ANALYSIS; DRUG EXPOSURE; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; POLYPHARMACY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; ADOLESCENT; CLINICAL TRIAL; DRUG INTERACTION; DRUG UTILIZATION; HEALTH CARE SURVEY; HOSPITAL; MULTICENTER STUDY; PEDIATRIC INTENSIVE CARE UNIT; PHARMACOEPIDEMIOLOGY; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG INTERACTIONS; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84960158142     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0000000000000684     Document Type: Article

References (41)

1. US Department of Health and Human Services Best Pharmaceuticals for Children Act Literature Reviews and Assessments. Available at: http://www.bpca.nichd.nih.gov/resources/reviews/index.cfm. Accessed September 12, 2014
2. Kweder S Programs Affecting Safety and Innovation in Pediatric Therapies. Available at: http://www.fda.gov/NewsEvents/Testimony/ucm153848.htm. Accessed September 12, 2014
3. Mizokami F Koide Y Noro T Polypharmacy with common diseases in hospitalized elderly patients. Am J Geriatr Pharmacother 2012 10 123 128
4. Hovstadius B Petersson G Factors leading to excessive polypharmacy. Clin Geriatr Med 2012 28 159 172
5. Feudtner C Dai D Hexem KR Prevalence of polypharmacy exposure among hospitalized children in the United States. Arch Pediatr Adolesc Med 2012 166 6 16
6. Edwards JD Houtrow AJ Vasilevskis EE Chronic conditions among children admitted to U.S. pediatric intensive care units: Their prevalence and impact on risk for mortality and prolonged length of stay. Crit Care Med 2012 40 2196 2203
7. McDonnell C Hum S Frndova H Pharmacotherapy in pediatric critical illness: A prospective observational study. Paediatr Drugs 2009 11 323 331
8. Papadopoulos J Smithburger PL Common drug interactions leading to adverse drug events in the intensive care unit: Management and pharmacokinetic considerations. Crit Care Med 2010 38 S126 S135
9. Hanlon JT Pieper CF Hajjar ER Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006 61 511 515
10. Johnell K Klarin I The relationship between number of drugs and potential drug-drug interactions in the elderly: A study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 2007 30 911 918
11. Nobili A Garattini S Mannucci PM Multiple diseases and polypharmacy in the elderly: Challenges for the internist of third millennium. J Co-morb 2011 1 28 44
12. Mouly S Meune C Bergmann JF Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: Focus on CYP3A4. Intensive Care Med 2009 35 417 429
13. Askari M Eslami S Louws M Frequency and nature of drug-drug interactions in the intensive care unit. Pharmacoepidemiol Drug Saf 2013 22 430 437
14. Feinstein J Dai D Zhong W Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals. Pediatrics 2015 135 e99 e108
15. Lazarou J Pomeranz BH Corey PN Incidence of adverse drug reactions in hospitalized patients: A meta-Analysis of prospective studies. JAMA 1998 279 1200 1205
16. Malone DC Abarca J Hansten PD Identification of serious drug-drug interactions: Results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc (2003) 2004 44 142 151
17. Aagaard L Christensen A Hansen EH Information about adverse drug reactions reported in children: A qualitative review of empirical studies. Br J Clin Pharmacol 2010 70 481 491
18. Harper MB Longhurst CA McGuire TL Children's Hospital Association CDS Working Group Core drug-drug interaction alerts for inclusion in pediatric electronic health records with computerized prescriber order entry. J Patient Saf 2014 10 59 63
19. Fisher BT Lindenauer PK Feudtner C Strom B Kimmel S Hennessy S In-Hospital Databases. Pharmacoepidemiology 2012 5th Edition. Hoboken, NJ Wiley-Blackwell 244 258. In
20. Hsieh EM Hornik CP Clark RH Best Pharmaceuticals for Children Act-Pediatric Trials Network Medication use in the neonatal intensive care unit. Am J Perinatol 2014 31 811 821
21. Alcorn J McNamara PJ Pharmacokinetics in the newborn. Adv Drug Deliv Rev 2003 55 667 686
22. Kearns GL Abdel-Rahman SM Alander SW Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med 2003 349 1157 1167
23. Feudtner C Feinstein JA Zhong W Pediatric complex chronic conditions classification system version 2: Updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr 2014 14 199
24. Barrons R Evaluation of personal digital assistant software for drug interactions. Am J Health Syst Pharm 2004 61 380 385
25. Vonbach P Dubied A Krähenbühl S Evaluation of frequently used drug interaction screening programs. Pharm World Sci 2008 30 367 374
26. Viktil KK Blix HS Moger TA Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007 63 187 195
27. Bushardt RL Massey EB Simpson TW Polypharmacy: Misleading, but manageable. Clin Interv Aging 2008 3 383 389
28. Haider SI Johnell K Weitoft GR The influence of educational level on polypharmacy and inappropriate drug use: A register-based study of more than 600,000 older people. J Am Geriatr Soc 2009 57 62 69
29. Reis AM Cassiani SH Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil. Clinics (Sao Paulo) 2011 66 9 15
30. Smithburger PL Kane-Gill SL Seybert AL Drug-drug interactions in the medical intensive care unit: An assessment of frequency, severity and the medications involved. Int J Pharm Pract 2012 20 402 408
31. Uijtendaal EV van Harssel LL Hugenholtz GW Analysis of potential drug-drug interactions in medical intensive care unit patients. Pharmacotherapy 2014 34 213 219
32. Womer J Zhong W Kraemer FW Variation of opioid use in pediatric inpatients across hospitals in the U.S. J Pain Symptom Manage 2014 48 903 914
33. Zuppa AF Adamson PC Mondick JT Drug utilization in the pediatric intensive care unit: Monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill children. J Clin Pharmacol 2005 45 1305 1312
34. Devlin JW The pharmacology of oversedation in mechanically ventilated adults. Curr Opin Crit Care 2008 14 403 407
35. Devlin JW Roberts RJ Pharmacology of commonly used analgesics and sedatives in the ICU: Benzodiazepines, propofol, and opioids. Crit Care Clin 2009 25 431 49, vii
36. Barr J Fraser GL Puntillo K American College of Critical Care Medicine Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013 41 263 306
37. Schweickert WD Kress JP Strategies to optimize analgesia and sedation. Crit Care 2008 12 Suppl 3 S6
38. Ineke Neutel C Skurtveit S Berg C Polypharmacy of potentially addictive medication in the older persons-quantifying usage. Pharmacoepidemiol Drug Saf 2012 21 199 206
39. Tay KY Ewald MB Bourgeois FT Use of QT-prolonging medications in US emergency departments, 1995-2009. Pharmacoepidemiol Drug Saf 2014 23 9 17
40. Takata GS Mason W Taketomo C Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals. Pediatrics 2008 121 e927 e935
41. Walsh KE Landrigan CP Adams WG Effect of computer order entry on prevention of serious medication errors in hospitalized children. Pediatrics 2008 121 e421 e427